Sociodemographic Factors of Asthma Prevalence and Costs Among Children and Adolescents in the United States, 2016–2021
Preventing Chronic Disease · 25.07.2024 · 21
DOI: 10.5888/pcd21.230449 ↗Kurz gefasst
Fachartikel in der Zeitschrift Preventing Chronic Disease, online erschienen am 25.07.2024. Verfasst von Nianyang Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centers for Disease Control and Prevention, National Center for Environmental Health, Division of Environmental Health Science and Practice, Asthma a…. Hauptthemen laut MEDLINE: Asthma, Sociodemographic Factors. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Centers for Disease Control and Prevention, National Center for Environmental Health, Division of Environmental Health Science and Practice, Asthma and Air Quality Branch, 4770 Buford Hwy, S106-6, Atlanta, GA 30341 (uth…
- Centers for Disease Control and Prevention, National Center for Environmental Health, Division of Environmental Health Science and Practice, Asthma and Air Quality Branch, Atlanta, Georgia.
Zitieren
APA
Wang, N., & Nurmagambetov, T. (2024). Sociodemographic Factors of Asthma Prevalence and Costs Among Children and Adolescents in the United States, 2016–2021. Preventing Chronic Disease, 21. https://doi.org/10.5888/pcd21.230449
Vancouver
Wang N, Nurmagambetov T. Sociodemographic Factors of Asthma Prevalence and Costs Among Children and Adolescents in the United States, 2016–2021. Preventing Chronic Disease. 2024;21. doi:10.5888/pcd21.230449
BibTeX
@article{Wang2024,
author = {Wang, Nianyang and Nurmagambetov, Tursynbek},
title = {Sociodemographic Factors of Asthma Prevalence and Costs Among Children and Adolescents in the United States, 2016–2021},
journal = {Preventing Chronic Disease},
year = {2024},
volume = {21},
doi = {10.5888/pcd21.230449}
}
EUVIMED